An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis

Nature Biotechnology

Volumn 21, Issue 3, 2003, Pages 294-301

  Chen, Cecil ^a   Grzegorzewski, Krzysztof J ^a   Barash, Steve ^a   Zhao, Qinghai ^a   Schneider, Helmut ^a   Wang, Qi ^a   Singh, Mallika ^a   Pukac, Laurie ^a   Bell, Adam C ^a   Duan, Roxanne ^a   Coleman, Tim ^a   Duttaroy, Alokesh ^a   Cheng, Susan ^a   Hirsch, Jon ^a   Zhang, Linyi ^a   Lazard, Yanick ^a   Fischer, Carrie ^a   Barber, Melisa Carey ^a   Ma, Zhi Dong ^a   Zhang, Ya Qin ^a   Reavey, Peter ^a   Zhong, Lilin ^a   Teng, Baiqin ^a   Sanyal, Indra ^a   Ruben, Steve M ^a   Blondel, Olivier ^a   Birse, Charles E ^a   more..

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; DNA; GENES; GLUCOSE; PROTEINS;

FUNCTIONAL GENOMICS;

BIOTECHNOLOGY;

ALGORITHM; ARTICLE; BIOASSAY; BIODIVERSITY; BIOINFORMATICS; BIOLOGICAL MONITORING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DNA LIBRARY; GENOMICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; LIPID METABOLISM; PEPTIDE SYNTHESIS; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DIABETES MELLITUS; DRUG DESIGN; GENE EXPRESSION PROFILING; GLUCOSE; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PROTEINS; RECOMBINANT PROTEINS; REFERENCE VALUES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; SYSTEMS INTEGRATION;

EID: 0037338037     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt795     Document Type: Article

References (48)

1. Harris, M.I. et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21, 518-524 (1998).
2. Taylor, S.I. Deconstructing type 2 diabetes. Cel1 97, 9-12 (1999).
3. Saltiel, A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517-529 (2001).
4. Nordlie, R.C., Foster, J.D. & Lange, A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19, 379-406 (1999).
5. Czech, M.P. & Corvera, S. Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274, 1865-1868 (1999).
6. Bergman, R.N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351-356 (2000).
7. Rorsman, P. The pancreatic β-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40, 487-495 (1997).
8. Adams, M.D. et al. Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252, 1651-1656 (1991).
9. Boguski, M.S. & Schuler, G.D. ESTablishing a human transcript map. Nat. Genet. 10,369-371 (1995).
10. Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
11. Venter, J.C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
12. Hogan, B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594 (1996).
13. Eddy, S.R. Profile hidden Markov models. Bioinformatics, 14, 755-763 (1998).
14. Barash, S., Wang, W. & Shi, Y. Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem. Biophys. Res. Commun. 294, 835-842 (2002).
15. Nielsen, H., Engelbrecht, J., Brunak, S. & von Heijne, G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10, 1-6 (1997).
16. Bairoch, A. & Boeckmann, B. The SWISS-PROT protein sequence data bank: current status. Nucleic Acids Res. 22, 3578-3580 (1994).
17. Magnusson, I., Rothman, D.L., Katz, L.D., Shulman, R.G. & Shulman, G.I. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J. Clin. Invest. 90, 1323-1327 (1992).
18. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB-β). Science 292, 1728-1731 (2001).
19. Cross, D.A., Alessi, D.R., Cohen, R, Andjelkovich, M. & Hemmings, B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995).
20. Kraegen, E.W., Cooney, G.J., Ye, J.M., Thompson, A.L. & Furler, S.M. The role of lipids in the pathogenesis of muscle insulin resistance and β-cell failure in type II diabetes and obesity. Exp. Clin. Endocrinol. Diabetes 109, S189-S201 (2001).
21. Laakso, M. Insulin resistance and its impact on the approach to therapy of type 2 diabetes. Int. J. Clin. Pract. (Suppl.) 8-12 (2001).
22. Castelein, H. et al. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269, 26754-26758 (1994).
23. Petty, K.J., Desvergne, B., Mitsuhashi, T. & Nikodem, V.M. Identification of a thyroid hormone response element in the malic enzyme gene. J. Biol. Chem. 265, 7395-7400 (1990).
24. Barroso, I. & Santisteban, R Insulin-induced early growth response gene (Egr-1) mediates a short term repression of rat malic enzyme gene transcription. J. Biol. Chem. 274, 17997-18004 (1999).
25. Horton, J.D., Goldstein, J.L. & Brown, M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002).
26. Becard, D. et al. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50, 2425-2430 (2001).
27. Formisano, P. et al. Insulin-activated protein kinase Cβ bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol. Cell Blol. 20, 6323-6333 (2000).
28. Machinal-Quelin, F., Dieudonne, M.N., Leneveu, M.C., Pecquery, R. & Giudicelli, Y. Pro-adipogenic effect of leptin on rat pre-adipocytes in vitro: activation of MAPK and STAT3 signaling pathways. Am. J. Physiol. Cell Physiol. 282, C853-C863 (2002).
29. Blagoev, B. et al. Inhibition of adipocyte differentiation by resistin-like molecule? Biochemical characterization of its oligomeric nature. J. Biol. Chem. 277, 42011-42016 (2002).
30. Luo, G. et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9, 2808-2820 (1995).
31. Dong, J. et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383, 531-535 (1996).
32. Song, J.J. et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136, 4293-4297 (1995).
33. Miller, A.F., Harvey, S.A., Thies, R.S. & Olson, M.S. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J. Biol. Chem. 275, 17937-17945 (2000).
34. Helm, G.A. et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J. Neurosurg. 92, 191-196 (2000).
35. Majumdar, M.K., Wang, E. & Morris, E.A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J. Cell Physiol. 189, 275-284 (2001).
36. Varady, P. et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum. Gene Ther. 12, 697-710 (2001).
37. Ploemacher, R.E., Engels, L.J., Mayer, A.E., Thies, S. & Neben, S. Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures. Leukemia 13, 428-437 (1999).
38. Lopez-Coviella, I., Berse, B., Krauss, R., Thies, R.S. & Blusztajn, J.K. Induction and maintenance of the neuronal cholinergic phenotype In the central nervous system by BMP-9. Science 289, 313-316 (2000).
39. Lang, S., Goldstein, M.S. & Levine, R. Influence of the liver on uptake of glucose by peripheral tissues. Am. J. Physiol. 177, 447-450 (1955).
40. Mertz, W. & Schwartz, K. An effect of liver extracts on glucose tolerance in rats. Am. J. Physiol. 203, 533-556 (1962).
41. Lautt, W.W. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can. J. Physiol. Pharmacol. 77, 553-562 (1999).
42. Fiscella, M. et al. TIP, a T cell factor identified using high-throughput screening approaches increases survival in an acute GVHD model. Nat. Biotechnol. 21, 302-307 (2003).
43. Boguski, M.S., Lowe, T.M. & Tolstoshev, C.M. dbEST - database for "expressed sequence tags". Nat. Genet. 4, 332-333 (1993).
44. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
45. Pruitt, K.D. & Maglott, D.R. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res. 29, 137-140 (2001).
46. Forrer, P., Tamaskovic, R. & Jaussi, R. Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities. Biot. Chem. 379, 1101-1111 (1998).
47. Wang, J.C., Stafford, J.M., Scott, D.K., Sutherland, C. & Granner, D.K. The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J. Biol. Chem. 275, 14717-14721 (2000).
48. National Research Council. Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, DC, 1996).